Lifecare ASA LIFE
OSL · Norway · Health Technology
NOK 0.4600-0.11 (-19.30%)
Market closed· · NOK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · NOK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Lifecare’s latest analyst update keeps the fair value price target steady at NOK 0.4, signalling that the central valuation anchor in the model is unchanged. Analysts link this to only modest tweaks around long term earnings assumptions and execution risks, rather than any shift in the headline target itself. As you read on, you will see how this stable NOK 0.4 view fits with recent news, the bullish and bearish arguments, and what to watch to stay on top of the evolving Lifecare story. Stay...
Lifecare’s NOK30 price target is now front and center again, with the fair value assumption held at NOK0.40 while discount rate inputs and peer comparisons are being revisited. Analysts are lining up that NOK30 level against recent NOK30 or $30 targets for peers such as Ethos, using it as a reference point for how the market is thinking about risk and long term earnings potential in this space. As you read on, you will see how this evolving narrative, both bullish and cautious, might shape...
Lifecare’s analyst fair value per share has been cut from NOK0.65 to NOK0.40, a sizeable reset that directly affects how you might frame risk and reward around the stock. Analysts link this lower target to revised expectations for the business, with more cautious revenue assumptions and updated inputs feeding both optimistic and cautious narratives. As you read on, you will see how these shifting views can help you track the evolving story and what it could mean for your own research on...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.